Sign in to follow this  
Followers 0
LaurenH

Weekly Clip Report June 5-9

2 posts in this topic

MONDAY, JUNE 5

Reuters
“Roche's Alecensa bests Pfizer's Xalkori in lung cancer trial”
https://www.reuters.com/article/us-health-cancer-roche-pfizer-idUSKBN18W1HH

Forbes
“A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here's What It Teaches Us”
https://www.forbes.com/sites/matthewherper/2017/06/03/a-new-cancer-drug-helped-almost-everyone-who-took-it-almost-heres-what-it-teaches-us/#677ea9e6b25f

The Telegraph (UK)
“Cancer Patients Who Enter Their Symptoms into an App Live Longer than Expected, Study Suggests”
http://www.telegraph.co.uk/science/2017/06/04/cancer-patients-enter-symptoms-app-live-longer-expected-study/

Patient Daily
“FDA OKs Novartis’ Zykadia for Metastatic Lung Cancer Affecting the Brain”http://patientdaily.com/stories/511122036-fda-oks-novartis-zykadia-for-metastatic-lung-cancer-affecting-the-brain

TUESDAY, JUNE 6

Drug Discovery & Development
“ASCO 2017: Investigational Agent Improves Survival Outcomes for EGFR-Positive Lung Cancer”
https://www.dddmag.com/article/2017/06/asco-2017-investigational-agent-improves-survival-outcomes-egfr-positive-lung-cancer

The Washington Post
“8 Things Doctors are Buzzing about at the Biggest Cancer Meeting”
https://www.washingtonpost.com/news/to-your-health/wp/2017/06/06/7-attention-grabbing-topics-at-the-nations-biggest-cancer-meeting/?utm_term=.39f88e8f0ae0

WEDNESDAY, JUNE 7

Fannin Sentinel
“Lungevity: Shining Light on the Invisible Disease”
http://fanninsentinel.news/?p=7581

PR Newswire
“Julie R. Brahmer, MD., MSc, is recognized by Continental Who's Who”
http://www.prnewswire.com/news-releases/julie-r-brahmer-md-msc-is-recognized-by-continental-whos-who-300469906.html

Healio
“Pembrolizumab Reduces Need for Second-Line Therapy in Advanced NSCLC”
http://www.healio.com/hematology-oncology/lung-cancer/news/online/{7d9e7f9c-c66a-4f06-9ab3-e95da959cad5}/pembrolizumab-reduces-need-for-second-line-therapy-in-advanced-nsclc

ASCO Daily News
“Studies Explore Targeted Therapies in Lung Cancer”
https://am.asco.org/studies-explore-targeted-therapies-lung-cancer

THURSDAY, JUNE 8

The New York Times
“Cancer Drug Proves to Be Effective Against Multiple Tumors”
https://www.nytimes.com/2017/06/08/health/cancer-drug-keytruda-tumors.html?_r=0

The New York Times
“When Your Personal War on Cancer Is Exhausting”
https://www.nytimes.com/2017/06/08/well/live/when-your-personal-war-on-cancer-is-exhausting.html?_r=0

EurekAlert
“Scientific Advances in Thoracic Oncology in 2016 Highlighted by the IASLC”
https://www.eurekalert.org/pub_releases/2017-06/iaft-sai060817.php

FRIDAY, JUNE 9

Healio
“Primary NSCLC May Be Underdiagnosed Among Patients with Metastatic Renal Cell Carcinoma”
http://www.healio.com/hematology-oncology/genitourinary-cancer/news/online/{97a56d74-d2e8-44d3-942a-7e8f636341b7}/primary-nsclc-may-be-underdiagnosed-among-patients-with-metastatic-renal-cell-carcinoma

Cure Today
“Expert Discusses the Future of EGFR+ and ALK+ Lung Cancer”
http://www.curetoday.com/articles/expert-discusses-the-future-of-egfr-and-alk-lung-cancer

USA Today
“’How Long Have I Got?’: Why Many Cancer Patients Don’t Have Answers ”
https://www.usatoday.com/story/news/2017/06/09/kaiser-how-long-have-got-doc-why-many-cancer-patients-dont-have-answers/102518488/

BridgetO likes this

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now
Sign in to follow this  
Followers 0